Blue Cross and Blue Shield conspired with Aetna and Quest Diagnostics to
monopolize the diagnostic lab test market in California, four
laboratories claim in a federal antitrust complaint.
Lead plaintiff Rheumatology Diagnostics Laboratory is joined as plaintiff by Pacific Breast Pathology Medical Corp., Hunter Laboratories, and Surgical Pathology Associates.
They claim Blue Shield of California, the Blue Cross and Blue Shield Association, Aetna and Quest Diagnostics conspired to corner the market by offering cut-rate deals to physician groups.
"Diagnostic testing represents less than 2 percent of spending by health plans, but nonetheless influences seventy (70) percent of all medical decisions," the complaint states.
Aetna is a leading health insurance company but its business model differs from Blue Cross's, according to www.healthinsuranceproviders.com .
Blue Cross is comprised of dozens of smaller, independent health insurance companies, which pay a licensing fee to use the "Blue Cross" logo. Insurance plans vary from state to state.
Read more: http://www.courthousenews.com/2012/11/19/52386.htm
Lead plaintiff Rheumatology Diagnostics Laboratory is joined as plaintiff by Pacific Breast Pathology Medical Corp., Hunter Laboratories, and Surgical Pathology Associates.
They claim Blue Shield of California, the Blue Cross and Blue Shield Association, Aetna and Quest Diagnostics conspired to corner the market by offering cut-rate deals to physician groups.
"Diagnostic testing represents less than 2 percent of spending by health plans, but nonetheless influences seventy (70) percent of all medical decisions," the complaint states.
Aetna is a leading health insurance company but its business model differs from Blue Cross's, according to www.healthinsuranceproviders.com .
Blue Cross is comprised of dozens of smaller, independent health insurance companies, which pay a licensing fee to use the "Blue Cross" logo. Insurance plans vary from state to state.
Read more: http://www.courthousenews.com/2012/11/19/52386.htm
No comments:
Post a Comment